News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Chadi Nabhan: ODAC voted “NO” on approving Blenrep 4 R/R Myeloma
Chadi Nabhan/chadinabhan.com
Jul 28, 2025, 15:12

Chadi Nabhan: ODAC voted “NO” on approving Blenrep 4 R/R Myeloma

Chadi Nabhan, Chief Medical Officer and Head of Strategy at Ryght, shared a post on X:

“Recently, ODAC voted “NO” on approving Blenrep 4 R/R Myeloma. In a back-to-back HUExpress, I get Vincent Rajkumar thoughts on that decision and I also host Greg to give us “behind the scenes” on what happened that day at ODAC.

Two must watch EPs coming your way this week.”

Proceed to the video attached to the post.

More posts featuring Chadi Nabhan on OncoDaily.

cancer Chadi Nabhan Myeloma ODAC OncoDaily Oncology Vincent Rajkumar
Special Coverage
Blog
Jul 28, 2025, 15:45
Make a Nomination for the Translational Cancer Researcher Award - EACR
Insight
Jul 28, 2025, 15:41
How Autoantibodies Influence Cancer Patients' Response to Immunotherapy - Fred Hutch Cancer Center
Blog
Jul 28, 2025, 15:36
Narjust Florez: Bringing Awareness to the Rising Incidence of Lung Cancer in Women
Blog
Jul 28, 2025, 15:34
Samson Boyo: Honored to Represent CureCervicalCancer at the 2nd National Cancer Summit 2025
Blog
Jul 28, 2025, 15:24
Spotlighting NSW’s World-Leading Efforts to Support People Impacted by Cancer - Cancer Institute NSW
Blog
Jul 28, 2025, 15:17
Jasmin Hundal: Grateful to Have Attended the ASCO-AACR MCCR Workshop
Blog
Jul 28, 2025, 15:12
Chadi Nabhan: ODAC voted "NO" on approving Blenrep 4 R/R Myeloma
Blog
Jul 28, 2025, 15:10
Expand Your Surgical Knowledge and Attend SSO 2026 For Free - Society of Surgical Oncology
Insight
Jul 28, 2025, 14:58
Gene Expression Profiling of Breast Cancer Brain Metastases - Mirrors of Medicine
Oncolibrary
Jul 28, 2025, 14:54
New Paper Alert: Real-World Study Confirms Chemoimmunotherapy Improves Survival in Resectable NSCLC, But Usage Remains Low
Blog
Jul 28, 2025, 14:45
Promising Opportunities to Address Organ Shortages and Unequal Access to Organ Transplantation - The Lancet
Blog
Jul 28, 2025, 14:18
Amer Zeidan: Pleasure to Co-Chair the Medical Crossfire in Hematologic Malignancies Meeting in New York City